NeuBase Therapeutics Inc (NBSE)

Finanzdaten der NeuBase Therapeutics Inc-Aktie (NBSE)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2023-09-30	2023-06-30	2023-03-31	2022-09-30	2022-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	23.72% 2.8132	3.6879	4.1643	7.7234	8.3606
Interest Income/Expense	83.29% 0.000122	0.00073	0.00235	0.00269	0.00282
Depreciation and Amortization	29.58% 0.133	0.1889	0.1874	0.1996	0.1953
Operating Income/Loss	23.72% -2.8132	-3.6879	-4.1643	-7.7234	-8.3606
Nonoperating Income/Loss	311.39% 0.9921	0.2412	0.0712	-	-
Income/Loss From Continuing Operations Before Tax	47.17% -1.8211	-3.4468	-4.0931	-7.6319	-8.4917
Income/Loss From Continuing Operations After Tax	47.17% -1.8211	-3.4468	-4.0931	-7.6319	-8.4917
Net Income/Loss	47.17% -1.8211	-3.4468	-4.0931	-7.6319	-8.4917
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	62.92% 2.7576	1.6926	33.55	-0.0688	32.26
Diluted Average Shares	62.92% 2.7576	1.6926	33.55	-0.0688	32.26
Basic Earnings Per Share	67.65% -0.66	-2.04	-0.12	-0.24	-0.26
Diluted Earnings Per Share	67.65% -0.66	-2.04	-0.12	-0.24	-0.26
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-